Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stimuvax in ER/PgR-positive advanced breast cancer
NCT00925548Phase 3Terminated
- Sponsor
- EMD Serono
- Start
- Sep 2009
- Primary completion
- Aug 2010
- Countries
- 12
01
Overview
A Phase 3 trial of tecemotide in breast cancer, sponsored by EMD Serono. Started Sep 2009; status: terminated.
02
Drugs
tecemotide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00925548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925548.